MC-1101

DRUG3 trials

Sponsors

MacuCLEAR, Inc.

Conditions

Age-Related Macular DegenerationNon-Exudative Age Related Macular DegenerationNonexudative Age Related Macular Degeneration

Phase 1

A Pilot Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Dry AMD

CompletedNCT01013376

MacuCLEAR, Inc.Age-Related Macular Degeneration

Start: 2009-08-31End: 2009-08-31Updated: 2009-11-13

Phase 2

Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration

TerminatedNCT01601483

MacuCLEAR, Inc.Nonexudative Age Related Macular Degeneration

Start: 2012-10-31End: 2013-03-31Updated: 2014-04-28

Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration

MacuCLEAR, Inc.Non-Exudative Age Related Macular Degeneration

Start: 2014-04-30End: 2016-04-30Target: 60Updated: 2014-04-30